Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30083557HIVENSG00000175868.14protein_codingCALCBNoNo797P10092
TVIS30029105HIVENSG00000175868.14protein_codingCALCBNoNo797P10092
TVIS20001107HPVENSG00000175868.14protein_codingCALCBNoNo797P10092
TVIS20064872HPVENSG00000175868.14protein_codingCALCBNoNo797P10092
TVIS20040972HPVENSG00000175868.14protein_codingCALCBNoNo797P10092
TVIS20049438HPVENSG00000175868.14protein_codingCALCBNoNo797P10092
TVIS20037680HPVENSG00000175868.14protein_codingCALCBNoNo797P10092
TVIS20041789HPVENSG00000175868.14protein_codingCALCBNoNo797P10092
TVIS20067017HPVENSG00000175868.14protein_codingCALCBNoNo797P10092
TVIS20049906HPVENSG00000175868.14protein_codingCALCBNoNo797P10092
TCGA Plot Options
Drug Information
GeneCALCB
DrugBank IDDB14042
Drug NameGalcanezumab
Target IDBE0002370
UniProt IDP10092
Regulation Typeantibody
PubMed IDs29089894
CitationsMonteith D, Collins EC, Vandermeulen C, Van Hecken A, Raddad E, Scherer JC, Grayzel D, Schuetz TJ, de Hoon J: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers. Front Pharmacol. 2017 Oct 17;8:740. doi: 10.3389/fphar.2017.00740. eCollection 2017.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL